Oncology estimand working group: newsletter 16th December 2022

Hi all,

We hope this reaches you well! Before the end of the year we would like to share again some recent developments, events, and achievements.

1 Updates

We have updated the events page with our past and upcoming appearances, including posting of presented slidedecks. Please let us know of further presentations, workshops, webinars, etc that are not on the list yet!
On 21st October DIA held a webinar in China, with a talk by Jiajun Xu from the conditional and marginal effect force. With a peak attendance of 4460 this likely sets a new record for a talk by this WG!
2nd December: Together with ASA NJ chapter the WG co-organized a webinar ASA New Jersey Chapter Webinar Series: Getting the question right: Applying the Estimand and Target Trial Frameworks with External Controls. See also Evgeny’s linkedin post.
In December, the Basel Biometrics Society organized two half-day seminars on Addressing intercurrent events: Treatment policy and hypothetical strategies Slides and recordings are available day 1 and day 2.

Continue the work in the task forces.
We are also again planning check-in TCs with our global regulatory partners and will reach out to task forces in due time.
At least two conference appearances are already planned:
- Talk at the Duke Industry statistics symposium.
- Entire invited session at the PSI conference.

Please routinely share slidedecks or links to other material that we can add to the events page.

You are invited to share the link to this newsletter broadly. To conclude, we invite you to regularly check out our webpage: www.oncoestimand.org.

Kind Regards,
Evgeny & Kaspar